PEN vs. STVN, SWAV, TFX, GMED, INSP, HAE, MMSI, PODD, IART, and GKOS
Should you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include Stevanato Group (STVN), Shockwave Medical (SWAV), Teleflex (TFX), Globus Medical (GMED), Inspire Medical Systems (INSP), Haemonetics (HAE), Merit Medical Systems (MMSI), Insulet (PODD), Integra LifeSciences (IART), and Glaukos (GKOS). These companies are all part of the "surgical & medical instruments" industry.
Penumbra (NYSE:PEN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends.
Stevanato Group has higher revenue and earnings than Penumbra. Stevanato Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
88.2% of Penumbra shares are held by institutional investors. Comparatively, 10.9% of Stevanato Group shares are held by institutional investors. 5.3% of Penumbra shares are held by company insiders. Comparatively, 0.7% of Stevanato Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Penumbra currently has a consensus target price of $317.25, suggesting a potential upside of 41.60%. Given Penumbra's stronger consensus rating and higher possible upside, equities analysts plainly believe Penumbra is more favorable than Stevanato Group.
Penumbra has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.
In the previous week, Penumbra had 3 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.06 beat Penumbra's score of 0.72 indicating that Stevanato Group is being referred to more favorably in the news media.
Penumbra received 757 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 80.43% of users gave Penumbra an outperform vote while only 63.16% of users gave Stevanato Group an outperform vote.
Stevanato Group has a net margin of 14.05% compared to Penumbra's net margin of 4.08%. Stevanato Group's return on equity of 14.87% beat Penumbra's return on equity.
Summary
Penumbra beats Stevanato Group on 11 of the 18 factors compared between the two stocks.
Get Penumbra News Delivered to You Automatically
Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Penumbra Competitors List
Related Companies and Tools